Effectiveness of Motivational Interview in Patients With Dyslipidemia (Dislip-EM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Hospital Universitario Reina Sofia.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hospital Universitario Reina Sofia
ClinicalTrials.gov Identifier:
NCT01282190
First received: January 21, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
  Purpose

Evaluate the effectiveness of motivational interviewing to improve lipid control and cardiovascular risk in patients with dyslipidemia.


Condition Intervention
Patients With Dyslipidemia
Behavioral: Motivational interview

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Effectiveness of Motivational Interview in Patients With Dyslipidemia Treated in Primary Care Consultations (Dislip-EM Study)

Resource links provided by NLM:


Further study details as provided by Hospital Universitario Reina Sofia:

Primary Outcome Measures:
  • lipid levels [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • cardiovascular risk [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 400
Study Start Date: June 2010
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Motivational interview Behavioral: Motivational interview
Motivational interview

  Eligibility

Ages Eligible for Study:   40 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • People diagnosed with dyslipidemia
  • To sign informed consent.

Exclusion Criteria:

  • Secondary hypercholesterolemia.
  • Familial hypercholesterolemia.
  • Deficiency syndromes family high density lipoprotein.
  • Subjects with a history of cardiac or cerebrovascular events.
  • Other chronic health problems such as diabetes or severe COPD.
  • Subjects with current diagnosis of cancer.
  • Patients with hepatic or renal disorders .
  • Subjects heavy drinkers.
  • Patients with long standing sick leave (more than 6 months).
  • Pregnant or breastfeeding.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01282190

Contacts
Contact: Luis A Pérula, Ph D +34 957012543 langel.perula.sspa@juntadeandalucia.es

Locations
Spain
Family Medicine Teaching Unit and Community Recruiting
Córdoba, Spain, 14011
Contact: Luis A Pérula, Ph D    +34 957012543    langel.perula.sspa@juntadeandalucia.es   
Principal Investigator: Luis A Pérula, Ph D         
Sponsors and Collaborators
Hospital Universitario Reina Sofia
  More Information

No publications provided by Hospital Universitario Reina Sofia

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luis A Pérula, Biomedical Research Foundation of Cordoba (FIBICO)
ClinicalTrials.gov Identifier: NCT01282190     History of Changes
Other Study ID Numbers: PI-0100/2008
Study First Received: January 21, 2011
Last Updated: January 21, 2011
Health Authority: Spain: Autonomic Committee of Clinical Trials (Andalusian)

Keywords provided by Hospital Universitario Reina Sofia:
dyslipidemia, motivational interview, prevention

Additional relevant MeSH terms:
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on September 30, 2014